datelliptium chloride has been researched along with Leukemia P388 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Auclair, C; Colas, C; Cros, S; Gros, P; Paoletti, C; Pepin, O; Pierre, A; Saucier, JM; Verschuere, B; Voisin, E | 1 |
1 other study(ies) available for datelliptium chloride and Leukemia P388
Article | Year |
---|---|
Physicochemical and pharmacological properties of the antitumor ellipticine derivative 2-(diethylamino-2-ethyl)9-hydroxy ellipticinium-chloride, HCl.
Topics: Adenocarcinoma; Alkaloids; Animals; Antineoplastic Agents; Cell Line; Chemical Phenomena; Chemistry, Physical; Colonic Neoplasms; DNA; Ellipticines; Leukemia L1210; Leukemia P388; Melanoma; Mutagenicity Tests; Salmonella | 1987 |